IL157597A0 - Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors - Google Patents
Diaminoquinazoline esters for use as dihydrofolate reductase inhibitorsInfo
- Publication number
- IL157597A0 IL157597A0 IL15759702A IL15759702A IL157597A0 IL 157597 A0 IL157597 A0 IL 157597A0 IL 15759702 A IL15759702 A IL 15759702A IL 15759702 A IL15759702 A IL 15759702A IL 157597 A0 IL157597 A0 IL 157597A0
- Authority
- IL
- Israel
- Prior art keywords
- diaminoquinazoline
- esters
- reductase inhibitors
- dihydrofolate reductase
- dihydrofolate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100694A SE0100694D0 (sv) | 2001-02-28 | 2001-02-28 | DHFR inhibitors |
SE0200008A SE0200008D0 (sv) | 2002-01-02 | 2002-01-02 | New pharmaceutically compounds |
PCT/GB2002/000888 WO2002068397A1 (en) | 2001-02-28 | 2002-02-28 | Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157597A0 true IL157597A0 (en) | 2004-03-28 |
Family
ID=26655401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15759702A IL157597A0 (en) | 2001-02-28 | 2002-02-28 | Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040092515A1 (ja) |
EP (1) | EP1366028A1 (ja) |
JP (1) | JP2004520414A (ja) |
KR (1) | KR20030086272A (ja) |
BR (1) | BR0207706A (ja) |
CA (1) | CA2439463A1 (ja) |
IL (1) | IL157597A0 (ja) |
MX (1) | MXPA03007699A (ja) |
WO (1) | WO2002068397A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050032807A1 (en) * | 2003-08-06 | 2005-02-10 | Rosenwald Lindsay A. | Methods of treating inflammatory diseases with ammonium salts of ornitihine derivatives |
AU2006334107A1 (en) * | 2005-12-30 | 2007-07-12 | Ranbaxy Laboratories Limited | Muscarinic receptor antagonists |
GB0608822D0 (en) * | 2006-05-04 | 2006-06-14 | Chroma Therapeutics Ltd | Inhibitors of DHFR |
WO2008020042A1 (en) * | 2006-08-16 | 2008-02-21 | Action Medicines, S.L. | Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases |
US7550674B2 (en) | 2007-02-22 | 2009-06-23 | Nexans | UTP cable |
SG176983A1 (en) | 2009-07-08 | 2012-02-28 | Dermira Canada Inc | Tofa analogs useful in treating dermatological disorders or conditions |
CN110719960B (zh) * | 2017-03-23 | 2024-03-08 | 梅哈里医学院 | 用于诊断和治疗炎性肠病的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL108630A0 (en) * | 1993-02-18 | 1994-05-30 | Fmc Corp | Insecticidal substituted 2,4-diaminoquinazolines |
-
2002
- 2002-02-28 BR BR0207706-0A patent/BR0207706A/pt not_active IP Right Cessation
- 2002-02-28 IL IL15759702A patent/IL157597A0/xx unknown
- 2002-02-28 WO PCT/GB2002/000888 patent/WO2002068397A1/en not_active Application Discontinuation
- 2002-02-28 KR KR10-2003-7011136A patent/KR20030086272A/ko not_active Application Discontinuation
- 2002-02-28 EP EP02700488A patent/EP1366028A1/en not_active Withdrawn
- 2002-02-28 MX MXPA03007699A patent/MXPA03007699A/es unknown
- 2002-02-28 CA CA002439463A patent/CA2439463A1/en not_active Abandoned
- 2002-02-28 US US10/468,151 patent/US20040092515A1/en not_active Abandoned
- 2002-02-28 JP JP2002567911A patent/JP2004520414A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002068397A1 (en) | 2002-09-06 |
JP2004520414A (ja) | 2004-07-08 |
BR0207706A (pt) | 2004-03-23 |
US20040092515A1 (en) | 2004-05-13 |
MXPA03007699A (es) | 2004-03-16 |
WO2002068397A8 (en) | 2003-12-04 |
KR20030086272A (ko) | 2003-11-07 |
EP1366028A1 (en) | 2003-12-03 |
CA2439463A1 (en) | 2002-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL373146A1 (en) | Pyridazinone-derivatives as pde4 inhibitors | |
AU2003271566A8 (en) | Pyrrolopyrazines as kinase inhibitors | |
ATE286049T1 (de) | Pyridazinonaldose reductase inhibitoren | |
EG25482A (en) | Inhibitors | |
PL363391A1 (en) | Phthalayinone-piperidino-derivatives as pde4 inhibitors | |
EP1496910A4 (en) | KINASE INHIBITORS | |
IL165515A0 (en) | Bisindolyl-maleimid derivatives as kinase inhibitors | |
AU2003255376A1 (en) | Piperidine-derivatives as pde4 inhibitors | |
AU2003286711A1 (en) | Indazolinone compositions useful as kinase inhibitors | |
IL157109A0 (en) | Quinazolines as mmp-13 inhibitors | |
HK1066546A1 (en) | Trifluoromethylpurines as phosphodiesterase 4 inhibitors | |
SI1569907T1 (sl) | Na nikotinamidu osnovani kinazni inhibitorji | |
ZA200510319B (en) | 6-arylamino-5-cyano-4-pyrimidinones as PDE9a inhibitors | |
HK1077762A1 (zh) | TFGß[轉化生長因子]的抑制劑 | |
EP1558609A4 (en) | KINASE INHIBITORS | |
IL165475A0 (en) | Nitrooxyderivatives of eyclooxygenase-2 inhibitors | |
AU2003250172A1 (en) | Compositions comprising hmg-coa reductase inhibitor | |
AU2003272719A8 (en) | Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents | |
ZA200409686B (en) | Bicyclic 6-aklylidene-penems as ?-lactamases inhibitors | |
EP1569907A4 (en) | NICOTINAMIDE-BASED KINASE HEMMER | |
EP1570847A4 (en) | PHOSPHODIESTERASE 10A HEMMER | |
IL157597A0 (en) | Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors | |
AU2003244080A1 (en) | Phosphodiesterase inhibitor | |
GB0001565D0 (en) | Dihydrofolate reductase inhibitors | |
AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors |